Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Pliant Therapeutics, Inc. PLRX

Full chart Compare
Set alert

Price alert · PLRX

All alert types
0.85 USD -0.01 (-1.03%)

At closeNov 5, 2026, 4:02 AM EST

0.84 -0.01 -1.15%

Pre-market · Nov 5, 4:02 AM ET

0.8416 Day range 0.8823
0.83 52-week range 1.82
YTD
-30.18%
1 year
-47.09%

Financial health

Altman Z-Score

-6.54 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

B-2 / 5 overall

  • DCF 3
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 3
  • P/E 1
  • P/B 5

Valuation

P/E -0.5×
FY 2017: -0.8×FY 2018: -11.6×FY 2019: -112×FY 2020: -19.4×FY 2021: -5.0×FY 2022: -6.6×FY 2023: -6.6×FY 2024: -3.8×FY 2025: -0.5×
FY 2017 5y median -5.0× FY 2025
P/S 0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 13.3×FY 2020: 19.3×FY 2021: 63.9×FY 2022: 83.9×FY 2023: 673×FY 2024: 0.0×FY 2025: 0.0×
FY 2017 5y median 63.9× FY 2025
P/B 0.4×
FY 2017: 5.1×FY 2018: -399×FY 2019: -1741×FY 2020: 2.9×FY 2021: 2.4×FY 2022: 2.6×FY 2023: 2.2×FY 2024: 2.6×FY 2025: 0.4×
FY 2017 5y median 2.4× FY 2025
P/FCF -0.6×
FY 2017: -0.9×FY 2018: -11.5×FY 2019: -204×FY 2020: -20.8×FY 2021: -6.3×FY 2022: -8.4×FY 2023: -9.1×FY 2024: -5.0×FY 2025: -0.6×
FY 2017 5y median -6.3× FY 2025
EV/EBITDA -0.4×
FY 2017: -0.7×FY 2018: -9.6×FY 2019: -5694×FY 2020: -18.8×FY 2021: -4.6×FY 2022: -6.6×FY 2023: -6.4×FY 2024: -3.8×FY 2025: -0.4×
FY 2017 5y median -4.6× FY 2025
EV/Sales 0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 11.8×FY 2020: 18.1×FY 2021: 58.0×FY 2022: 82.0×FY 2023: 640×FY 2024: 0.0×FY 2025: 0.0×
FY 2017 5y median 58.0× FY 2025
FCF Yield -171.9%
FY 2017: -107.1%FY 2018: -8.7%FY 2019: -0.5%FY 2020: -4.8%FY 2021: -16.0%FY 2022: -11.9%FY 2023: -11.0%FY 2024: -20.0%FY 2025: -171.9%
FY 2017 5y median -16.0% FY 2025

Profitability

Gross Margin 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 100.0%FY 2020: 100.0%FY 2021: 100.0%FY 2022: 100.0%FY 2023: 100.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 100.0% FY 2025
Operating Margin 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: -2.2%FY 2020: -99.6%FY 2021: -1288.1%FY 2022: -1313.4%FY 2023: -11654.7%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median -1288.1% FY 2025
Net Margin 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: -1.1%FY 2020: -99.3%FY 2021: -1284.5%FY 2022: -1273.3%FY 2023: -10211.1%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median -1273.3% FY 2025
ROE -82.4%
FY 2017: -616.5%FY 2018: 3432.7%FY 2019: 145.1%FY 2020: -14.7%FY 2021: -48.9%FY 2022: -39.4%FY 2023: -34.1%FY 2024: -69.2%FY 2025: -82.4%
FY 2017 5y median -48.9% FY 2025
ROIC -71.4%
FY 2017: -545.3%FY 2018: -50.3%FY 2019: -1.1%FY 2020: -14.7%FY 2021: -47.3%FY 2022: -38.6%FY 2023: -38.0%FY 2024: -62.7%FY 2025: -71.4%
FY 2017 5y median -47.3% FY 2025
ROA -66.3%
FY 2017: -314.7%FY 2018: -45.5%FY 2019: -0.5%FY 2020: -14.1%FY 2021: -44.0%FY 2022: -35.2%FY 2023: -31.5%FY 2024: -53.0%FY 2025: -66.3%
FY 2017 5y median -44.0% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: -26.7%FY 2021: -81.9%FY 2022: 27.9%FY 2023: -83.7%FY 2024: -100.0%FY 2025: 0.0%
FY 2017 FY 2025
Operating Income 34.3%
FY 2017: 0.0%FY 2018: -68.5%FY 2019: 96.0%FY 2020: -3283.0%FY 2021: -134.2%FY 2022: -30.4%FY 2023: -44.8%FY 2024: -24.0%FY 2025: 34.3%
FY 2017 FY 2025
EPS (diluted) 30.0%
FY 2017: 0.0%FY 2018: 92.9%FY 2019: 89.6%FY 2020: -515.8%FY 2021: -131.6%FY 2022: -8.5%FY 2023: 6.5%FY 2024: -26.2%FY 2025: 30.0%
FY 2017 FY 2025
Free Cash Flow 19.2%
FY 2017: 0.0%FY 2018: -67.2%FY 2019: 87.9%FY 2020: -944.8%FY 2021: -99.5%FY 2022: -24.5%FY 2023: -21.7%FY 2024: -35.9%FY 2025: 19.2%
FY 2017 FY 2025

Financial Health

Current Ratio 12.0×
FY 2017: 1.5×FY 2018: 12.1×FY 2019: 13.7×FY 2020: 25.1×FY 2021: 12.4×FY 2022: 14.2×FY 2023: 17.7×FY 2024: 10.9×FY 2025: 12.0×
FY 2017 5y median 12.4× FY 2025
Quick Ratio 12.0×
FY 2017: 1.5×FY 2018: 12.1×FY 2019: 13.7×FY 2020: 25.1×FY 2021: 12.4×FY 2022: 14.2×FY 2023: 17.7×FY 2024: 10.9×FY 2025: 12.0×
FY 2017 5y median 12.4× FY 2025
Debt / Equity 0.2×
FY 2017: 0.0×FY 2018: -0.6×FY 2019: -1.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.1×FY 2023: 0.0×FY 2024: 0.2×FY 2025: 0.2×
FY 2017 5y median 0.1× FY 2025
Net Debt / EBITDA 0.1×
FY 2017: 0.2×FY 2018: 2.0×FY 2019: 723×FY 2020: 1.3×FY 2021: 0.5×FY 2022: 0.1×FY 2023: 0.3×FY 2024: 0.1×FY 2025: 0.1×
FY 2017 5y median 0.1× FY 2025
Interest Coverage -58.6×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: -5.7×FY 2020: -114×FY 2021: 0.0×FY 2022: -161×FY 2023: -145×FY 2024: -75.5×FY 2025: -58.6×
FY 2017 5y median -75.5× FY 2025

Dividends

Dividend Yield 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31